Literature DB >> 15324300

Efficient production of active chicken avidin using a bacterial signal peptide in Escherichia coli.

Vesa P Hytönen1, Olli H Laitinen, Tomi T Airenne, Heidi Kidron, Niko J Meltola, Eevaleena J Porkka, Jarno Hörhä, Tiina Paldanius, Juha A E Määttä, Henri R Nordlund, Mark S Johnson, Tiina A Salminen, Kari J Airenne, Seppo Ylä-Herttuala, Markku S Kulomaa.   

Abstract

Chicken avidin is a highly popular tool with countless applications in the life sciences. In the present study, an efficient method for producing avidin protein in the periplasmic space of Escherichia coli in the active form is described. Avidin was produced by replacing the native signal sequence of the protein with a bacterial OmpA secretion signal. The yield after a single 2-iminobiotin-agarose affinity purification step was approx. 10 mg/l of virtually pure avidin. Purified avidin had 3.7 free biotin-binding sites per tetramer and showed the same biotin-binding affinity and thermal stability as egg-white avidin. Avidin crystallized under various conditions, which will enable X-ray crystallographic studies. Avidin produced in E. coli lacks the carbohydrate chains of chicken avidin and the absence of glycosylation should decrease the non-specific binding that avidin exhibits towards many materials [Rosebrough and Hartley (1996) J. Nucl. Med. 37, 1380-1384]. The present method provides a feasible and inexpensive alternative for the production of recombinant avidin, avidin mutants and avidin fusion proteins for novel avidin-biotin technology applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324300      PMCID: PMC1134122          DOI: 10.1042/BJ20041114

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  Foreword and introduction to the book (strept)avidin-biotin system.

Authors:  M Wilchek; E A Bayer
Journal:  Biomol Eng       Date:  1999-12-31

2.  DNA cloning using in vitro site-specific recombination.

Authors:  J L Hartley; G F Temple; M A Brasch
Journal:  Genome Res       Date:  2000-11       Impact factor: 9.043

3.  Development and characterization of a series of soluble tetrameric and monomeric streptavidin muteins with differential biotin binding affinities.

Authors:  M H Qureshi; J C Yeung; S C Wu; S L Wong
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

4.  A plasmid system for optimization of Fab' production in Escherichia coli: importance of balance of heavy chain and light chain synthesis.

Authors:  David P Humphreys; Bruce Carrington; Leigh C Bowering; Ravindra Ganesh; Mukesh Sehdev; Bryan J Smith; Lloyd M King; Dominic G Reeks; Alastair Lawson; Andrew G Popplewell
Journal:  Protein Expr Purif       Date:  2002-11       Impact factor: 1.650

Review 5.  Understanding the art of producing protein and nonprotein molecules in Escherichia coli.

Authors:  P Balbás
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

6.  The relationship of glycosylation and isoelectric point with tumor accumulation of avidin.

Authors:  Z Yao; M Zhang; H Sakahara; Y Nakamoto; T Higashi; S Zhao; N Sato; Y Arano; J Konishi
Journal:  J Nucl Med       Date:  1999-03       Impact factor: 10.057

7.  Mutation of a critical tryptophan to lysine in avidin or streptavidin may explain why sea urchin fibropellin adopts an avidin-like domain.

Authors:  O H Laitinen; K J Airenne; A T Marttila; T Kulik; E Porkka; E A Bayer; M Wilchek; M S Kulomaa
Journal:  FEBS Lett       Date:  1999-11-12       Impact factor: 4.124

8.  High-level periplasmic expression in Escherichia coli using a eukaryotic signal peptide: importance of codon usage at the 5' end of the coding sequence.

Authors:  D P Humphreys; M Sehdev; A P Chapman; R Ganesh; B J Smith; L M King; D J Glover; D G Reeks; P E Stephens
Journal:  Protein Expr Purif       Date:  2000-11       Impact factor: 1.650

9.  A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.

Authors:  J Schultz; Y Lin; J Sanderson; Y Zuo; D Stone; R Mallett; S Wilbert; D Axworthy
Journal:  Cancer Res       Date:  2000-12-01       Impact factor: 12.701

10.  Chicken avidin-related proteins show altered biotin-binding and physico-chemical properties as compared with avidin.

Authors:  Olli H Laitinen; Vesa P Hytönen; Mervi K Ahlroth; Olli T Pentikäinen; Ciara Gallagher; Henri R Nordlund; Vladimir Ovod; Ari T Marttila; Eevaleena Porkka; Sanna Heino; Mark S Johnson; Kari J Airenne; Markku S Kulomaa
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

View more
  19 in total

1.  Delivery of a peptide radiopharmaceutical to brain with an IgG-avidin fusion protein.

Authors:  Qing-Hui Zhou; Jeff Zhiqiang Lu; Eric Ka-Wai Hui; Ruben J Boado; William M Pardridge
Journal:  Bioconjug Chem       Date:  2011-07-06       Impact factor: 4.774

2.  Tetravalent single-chain avidin: from subunits to protein domains via circularly permuted avidins.

Authors:  Henri R Nordlund; Vesa P Hytönen; Jarno Hörhä; Juha A E Määttä; Daniel J White; Katrin Halling; Eevaleena J Porkka; J Peter Slotte; Olli H Laitinen; Markku S Kulomaa
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

3.  Rhizavidin from Rhizobium etli: the first natural dimer in the avidin protein family.

Authors:  Satu H Helppolainen; Kirsi P Nurminen; Juha A E Määttä; Katrin K Halling; J Peter Slotte; Tuulia Huhtala; Timo Liimatainen; Seppo Ylä-Herttuala; Kari J Airenne; Ale Närvänen; Janne Jänis; Pirjo Vainiotalo; Jarkko Valjakka; Markku S Kulomaa; Henri R Nordlund
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

4.  The highly dynamic oligomeric structure of bradavidin II is unique among avidin proteins.

Authors:  Jenni Leppiniemi; Amit Meir; Niklas Kähkönen; Sampo Kukkurainen; Juha A Määttä; Markus Ojanen; Janne Jänis; Markku S Kulomaa; Oded Livnah; Vesa P Hytönen
Journal:  Protein Sci       Date:  2013-06-06       Impact factor: 6.725

5.  Bifunctional avidin with covalently modifiable ligand binding site.

Authors:  Jenni Leppiniemi; Juha A E Määttä; Henrik Hammaren; Mikko Soikkeli; Mikko Laitaoja; Janne Jänis; Markku S Kulomaa; Vesa P Hytönen
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

6.  Construction of chimeric dual-chain avidin by tandem fusion of the related avidins.

Authors:  Tiina A Riihimäki; Sampo Kukkurainen; Suvi Varjonen; Jarno Hörhä; Thomas K M Nyholm; Markku S Kulomaa; Vesa P Hytönen
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

7.  Modification of the loops in the ligand-binding site turns avidin into a steroid-binding protein.

Authors:  Tiina A Riihimäki; Soili Hiltunen; Martina Rangl; Henri R Nordlund; Juha A E Määttä; Andreas Ebner; Peter Hinterdorfer; Markku S Kulomaa; Kristiina Takkinen; Vesa P Hytönen
Journal:  BMC Biotechnol       Date:  2011-06-09       Impact factor: 2.563

8.  Avidin related protein 2 shows unique structural and functional features among the avidin protein family.

Authors:  Vesa P Hytönen; Juha A E Määttä; Heidi Kidron; Katrin K Halling; Jarno Hörhä; Tuomas Kulomaa; Thomas K M Nyholm; Mark S Johnson; Tiina A Salminen; Markku S Kulomaa; Tomi T Airenne
Journal:  BMC Biotechnol       Date:  2005-10-07       Impact factor: 2.563

9.  Structural and functional characteristics of xenavidin, the first frog avidin from Xenopus tropicalis.

Authors:  Juha A E Määttä; Satu H Helppolainen; Vesa P Hytönen; Mark S Johnson; Markku S Kulomaa; Tomi T Airenne; Henri R Nordlund
Journal:  BMC Struct Biol       Date:  2009-09-29

10.  Structure of bradavidin-C-terminal residues act as intrinsic ligands.

Authors:  Jenni Leppiniemi; Toni Grönroos; Juha A E Määttä; Mark S Johnson; Markku S Kulomaa; Vesa P Hytönen; Tomi T Airenne
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.